🇺🇸 FDA
Patent

US 9821023

Methods for the treatment of central nervous system (CNS) disorders and mood disorders

granted A61KA61K38/10A61K38/12

Quick answer

US patent 9821023 (Methods for the treatment of central nervous system (CNS) disorders and mood disorders) held by Arizona Board of Regents on Behalf of the University of Arizona expires Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arizona Board of Regents on Behalf of the University of Arizona
Grant date
Tue Nov 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K38/10, A61K38/12, A61K38/22, A61K47/24